Is enough oxygen too much? by Schumacker, Paul T
Intensivists direct much eﬀ  ort toward maintaining tissue 
oxygenation in critically ill patients. While the conse-
quences of oxygen deprivation are well known, we also 
know that excessive oxygenation creates new problems 
because hyperoxia exacerbates lung injury. So like many 
things in life, ‘too much’ is not the solution to ‘not 
enough’.
Assessments of tissue oxygenation have taught us that 
‘normoxia’ diﬀ   ers among organs, and that tissue 
oxygenation can decrease when the environment or 
activity levels change. For example, lung alveolar cells 
normally reside under 14% O2, while oxygenation in 
intestinal epithelium can be less than 2%. Severe exercise 
decreases myocardial oxygenation from 4% to less than 
1% O2, while high altitude induces systemic hypoxemia. 
During embryonic development, systemic oxygenation in 
the fetus is severely hypoxic by comparison to the adult.
While severe hypoxia can threaten survival at any stage 
of life, it is interesting that our cells often experience 
signiﬁ  cant hypoxia without sustaining injury. Moreover, 
we have learned that both cells and organisms quickly 
acclimate to lower oxygen environments. Th  is is evi-
denced by altitude-acclimated climbers near the summit 
of Mt Everest who were alert with arterial PO2 less than 
25 mmHg! A similar level in a critically ill patient would 
be ominous. So why is hypoxia tolerated well in some 
circumstances but not in others?
In this issue of Critical Care, Dr Martin and colleagues 
consider the eﬀ  ects of hypoxia on physiology, and they 
review mechanisms allowing cells and organisms to 
tolerate oxygen deprivation without sustaining injury [1]. 
One mechanism involves the up-regulation of protective 
genes by hypoxia-inducible factor (HIF) transcription 
factors [2]. Th  e cadre of genes controlled by HIF varies 
among cell types, but generally includes the expression of 
glycolytic enzymes, glucose transporters, vascular growth 
factors, and genes regulating vascular tone and systemic 
oxygen transport [3]. HIF also contributes to the down-
regulation of mitochondrial respiration, which lessens 
tissue need for oxygen. Loss of HIF is lethal during 
embryonic development, largely because hypoxia acts as 
a morphogen controlling migration and diﬀ  erentiation of 
cells in the embryo and placenta [4].
Other systems engaged by hypoxia include AMP-
depen  dent protein kinase (AMPK), which responds to 
increases in cellular [AMP] and is also activated by 
hypoxia. AMPK preserves energy substrate supply by up-
regulating glycolysis and fatty acid oxidation [5]. AMPK 
also regulates other biological processes.
Interestingly, O2 acts as a signal in triggering the activa-
tion of both HIF and AMPK during hypoxia by releasing 
low levels of reactive oxygen species (ROS) from the 
electron transport chain [6]. Th  ese ROS migrate to the 
inter-membrane space where they can escape to the 
cytosol and trigger the activation of HIF and AMPK [7]. 
Th  us,  O2 acts in a paradoxical manner as a signaling mole-
cule activating protective mechanisms during hypoxia.
Martin and colleagues raise the provocative concept of 
‘permissive hypoxia’ in critical illness. To be sure, the 
degree to which hypoxemia should be corrected is 
incompletely understood. A reduction in cellular energy 
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Human cells require O2 for their energy supply, and 
critical illness can threaten the effi   cient delivery of 
O2 in accordance with tissue metabolic needs. In 
the accompanying article, Martin and colleagues 
point out that hypoxia is a normal and well-
tolerated stress during embryonic development. 
A better understanding of how fetal cells survive 
these conditions and how adult cells adapt to high 
altitude exposure may provide insight into how these 
mechanisms might be engaged in the treatment of 
hypoxemic patients. They suggest that ‘permissive 
hypoxia’ represents a therapeutic possibility. But 
before we turn down the inspired O2 levels we should 
consider the broader eff  ects of hypoxia on tissue repair 
in critical illness.
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could lessen the consequences of oxygen deprivation. But 
before we reach for the FIO2 control on the ventilator, we 
should consider other arguments. First, organ failure is 
essentially a situation where cells fail to perform their 
normal tissue function. In heart failure, cardiomyocytes 
are alive yet they fail to contract normally. In hypoxic 
tissues, adaptive responses might foster survival, but the 
consequences for organ function can be catastrophic. For 
example, in hypoxic lungs ROS signals activate AMPK, 
which triggers internalization of the epithelial Na,K-
ATPase, an enzyme essential for alveolar edema re  absor  p-
tion [8]. Hence, responses triggered by hypoxia may not 
optimize tissue repair and survival in the critically ill. 
Finally, intensivists need to know whether all cells in a 
tissue are oxygenated. Microvascular heterogeneity in the 
patient can create local hypoxic areas within excessively 
perfused regions. At the tissue level perfusion seems 
adequate, yet some cells are struggling in ‘hypoxic 
islands’. A parallel situation occurs in solid tumors, where 
local cellular anoxia occurs despite high blood ﬂ  ows and 
excessive (albeit abnormally structured) capillary density 
[9]. So high overall blood ﬂ  ow does not guarantee uni-
form oxygenation.
In summary, hypoxia triggers protective responses, but 
not all of these are adaptive at the tissue level. A better 
understanding of the heterogeneity of microvascular 
oxygen supply in the critically ill patient would help us 
begin to understand the situation before we turn down 
the oxygen.
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